HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Wellness Dietary Supplements Launches

Don’t Let COVID Bring You Down: New German Immunity Boosters From Stada, Pascoe And More

  • News

Executive Summary

New German wellness launches: Immunity boosting food supplements from Stada, Pascoe, Dr Scheffler, Queisser and Infecto.

You may also be interested in...



German OTC Marketing Round-Up: Allergy Launches From Novartis, Hevert, Dermapharm And Bencard

OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard. 

COVID-19 Drives UK Consumers To Pharmacy And E-Commerce – J&J Survey

UK consumers are looking to pharmacy for help with selecting OTCs during the coronavirus pandemic, as well as turning increasingly to e-commerce, finds a recent survey by Johnson & Johnson Consumer Health.

UK CBD Industry Welcomes FSA Clarification On Novel Food Evidence Requirement

“With so little publicly available information on the safety of CBD we anticipate that directly relevant studies will be needed,” explains the UK Food Standards Agency, in response to confusion within the country's CBD industry. 

Table

View full table

Topics

Tags:
Wellness Dietary Supplements Launches
UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By